Taking over a second chair
01.10.2015 - Novartis Chairman Joerg Reinhardt is taking over as chairman of the Novartis Foundation’s Board of Trustees.
Reinhardt, who holds a Ph.D. in pharmaceutical sciences from German Saarland University, previously served as chairman of the board of management and the executive committee of Bayer HealthCare. Prior to that, he held the position of Chief Operating Officer of Novartis from 2008 to 2010, and as Head of the Vaccines and Diagnostics Division of Novartis from 2006 to 2008. He also served as Chairman of the Board of the Genomics Institute of the Novartis Research Foundation in the US from 2000 to 2010, as a member of the supervisory board of MorphoSys from 2001 to 2004, and as a member of the board of directors of Lonza Group AG in Switzerland from 2012 to 2013.
Reinhardt succeeds Andrin Oswald. Peter Piot of the London School of Hygiene & Tropical Medicine, Rebecca Weintraub of Harvard Medical School, and Mr. Rainer Boehm from Novartis Pharmaceuticals have also been appointed to the foundation’s trustee board. Previous Board members George Gunn and Jean-Marie Lehn stepped down in the past year.http://www.european-biotechnology-news.com/people/bio-people/2015/joerg-reinhardt.html